Authors:
Luettig, B
Kaiser, M
Bode, U
Bell, EB
Sparshott, SM
Bette, M
Westermann, J
Citation: B. Luettig et al., Naive and memory T cells migrate in comparable numbers through the normal rat lung - Only effector T cells accumulate and proliferate in the lamina propria of the bronchi, AM J RESP C, 25(1), 2001, pp. 69-77
Authors:
Fleischhack, G
Schmidt-Niemann, M
Wulff, B
Havers, W
Marklein, G
Hasan, C
Bode, U
Citation: G. Fleischhack et al., Piperacillin, beta-lactam inhibitor plus gentamicin as empirical therapy of a sequential regimen in febrile neutropenia of pediatric cancer patients, SUPP CARE C, 9(5), 2001, pp. 372-379
Authors:
Fleischhack, G
Hartmann, C
Simon, A
Wulff, B
Havers, W
Marklein, G
Hasan, C
Bode, U
Citation: G. Fleischhack et al., Meropenem versus ceftazidime as empirical monotherapy in febrile neutropenia of paediatric patients with cancer, J ANTIMICRO, 47(6), 2001, pp. 841-853
Authors:
Luettig, B
Sponholz, A
Heerwagen, C
Bode, U
Westermann, J
Citation: B. Luettig et al., Recent thymic emigrants (CD4(+)) continuously migrate through lymphoid organs: Within the tissue they alter surface molecule expression, SC J IMMUN, 53(6), 2001, pp. 563-571
Authors:
Schlegel, U
Pels, H
Glasmacher, A
Kleinschmidt, R
Schmidt-Wolf, I
Helmstaedter, C
Fliessbach, K
Deckert, M
Van Roost, D
Fimmers, R
Bode, U
Klockgether, T
Citation: U. Schlegel et al., Combined systemic and intraventricular chemotherapy in primary CNS lymphoma: a pilot study, J NE NE PSY, 71(1), 2001, pp. 118-122
Citation: U. Bode et al., Gut-derived effector T cells circulating in the blood of the rat: preferential re-distribution by TGF beta-1 and IL-4 maintained proliferation, EUR J IMMUN, 31(7), 2001, pp. 2116-2125
Authors:
Fleischhack, G
Kambeck, I
Cipic, D
Hasan, C
Bode, U
Citation: G. Fleischhack et al., Interpretation of inflammatory markers in feverish cancer patients with orwithout neutropenia at admission - Reply, BR J HAEM, 114(2), 2001, pp. 490-491
Authors:
Fleischhack, G
Reif, S
Hasan, C
Jaehde, U
Hettmer, S
Bode, U
Citation: G. Fleischhack et al., Feasibility of intraventricular administration of etoposide in patients with metastatic brain tumours, BR J CANC, 84(11), 2001, pp. 1453-1459
Authors:
Fleischhack, G
Hassan, C
Graf, N
Mann, G
Bode, U
Citation: G. Fleischhack et al., IDA-FLAG - An effective reinduction therapy for poor prognosis AML of childhood - Report of a multicenter phase II trial, HEMAT BLOOD, 40, 2001, pp. 544-552
Authors:
Kornak, U
Schulz, A
Friedrich, W
Uhlhaas, S
Kremens, B
Voit, T
Hasan, C
Bode, U
Jentsch, TJ
Kubisch, C
Citation: U. Kornak et al., Mutations in the a3 subunit of the vacuolar H+-ATPase cause infantile malignant osteopetrosis, HUM MOL GEN, 9(13), 2000, pp. 2059-2063
Authors:
Simon, A
Fleischhack, G
Hasan, C
Bode, U
Engelhart, S
Kramer, MH
Citation: A. Simon et al., Surveillance for nosocomial and central line-related infections among pediatric hematology-oncology patients, INFECT CONT, 21(9), 2000, pp. 592-596
Authors:
Fleischhack, G
Cipic, D
Juettner, J
Hasan, C
Bode, U
Citation: G. Fleischhack et al., Procalcitonin - a sensitive inflammation marker of febrile episodes in neutropenic children with cancer, INTEN CAR M, 26, 2000, pp. S202-S211
Authors:
Janssen, G
Bode, U
Breu, H
Dohrn, B
Engelbrecht, V
Gobel, U
Citation: G. Janssen et al., Boswellic acids in the palliative therapy of children with progressive or relapsed brain tumors, KLIN PADIAT, 212(4), 2000, pp. 189-195
Authors:
Fleischhack, G
Kambeck, I
Cipic, D
Hasan, C
Bode, U
Citation: G. Fleischhack et al., Procalcitonin in paediatric cancer patients: its diagnostic relevance is superior to that of C-reactive protein, interleukin 6, interleukin 8, soluble interleukin 2 receptor and soluble tumour necrosis factor receptor II, BR J HAEM, 111(4), 2000, pp. 1093-1102
Authors:
Bode, U
Bradke, H
Eichhammer, W
Gruber, E
Jochem, E
Kowener, D
Mannsbart, W
Patel, M
Radgen, P
Reichert, J
Schleich, J
Schlomann, B
Schmid, C
Walz, R
Citation: U. Bode et al., Rational energy usage, BRENN WARME, 52(4), 2000, pp. 86-91
Authors:
Exton, MS
Schult, M
Donath, S
Strubel, T
Bode, U
Del Rey, A
Westermann, J
Schedlowski, M
Citation: Ms. Exton et al., Conditioned immunosuppression makes subtherapeutic cyclosporin effective via splenic innervation, AM J P-REG, 45(6), 1999, pp. R1710-R1717
Authors:
Dame, C
Albers, N
Hasan, C
Bode, U
Eigel, A
Hansmann, M
Brenner, R
Bartmann, P
Citation: C. Dame et al., Homozygous alpha-thalassaemia and hypospadias - common aetiology or incidental association? Long-term survival of Hb Bart's hydrops syndrome leads tonew aspects for counselling of alpha-thalassaemic traits, EUR J PED, 158(3), 1999, pp. 217-220
Authors:
Fuchs, J
Bode, U
von Schweinitz, D
Weinel, P
Erttmann, R
Harms, D
Mildenberger, D
Citation: J. Fuchs et al., Analysis of treatment efficiency of carboplatin and etoposide in combination with radical surgery in advanced and recurrent childhood hepatoblastoma:A report of the German Cooperative Pediatric Liver Tumor Study HB 89 and HE 94, KLIN PADIAT, 211(4), 1999, pp. 305-309
Authors:
Bode, U
Hasan, C
Hulsmann, B
Fleischhack, G
Citation: U. Bode et al., Recancostat compositum (R) therapy does not prevent tumor progression in young cancer patients, KLIN PADIAT, 211(4), 1999, pp. 353-355